Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Phillips

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer ModelsDanlin Sun, Anna S Nikonova, Peishan Zhang, et al.
ACS Combinatorial Science|August 13, 2016
Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral FragmentsSina Haftchenary, Shawn D Nelson, Laura Furst, et al.
Science (New York, N.Y.)|December 15, 2015
Polysialylation controls dendritic cell trafficking by regulating chemokine recognitionEva Kiermaier, Christine Moussion, Christopher T Veldkamp, et al.
ACS Chemical Biology|May 26, 2016
Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoThomas B Sundberg, Yanke Liang, Huixian Wu, et al.
Scientific Reports|October 29, 2017
Behaviorally-determined sleep phenotypes are robustly associated with adaptive functioning in individuals with low functioning autismSimonne Cohen, Ben D Fulcher, Shantha M W Rajaratnam, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Nature Chemical Biology|August 15, 2017
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cellsLiv Johannessen, Thomas B Sundberg, Daniel J O'Connell, et al.
Molecular Cancer Therapeutics|December 30, 2021
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid TumorsJennifer R Diamond, Todd M Pitts, Dana Ungermannova, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer ModelsDanlin Sun, Anna S Nikonova, Peishan Zhang, et al.
ACS Combinatorial Science|August 13, 2016
Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral FragmentsSina Haftchenary, Shawn D Nelson, Laura Furst, et al.
Science (New York, N.Y.)|December 15, 2015
Polysialylation controls dendritic cell trafficking by regulating chemokine recognitionEva Kiermaier, Christine Moussion, Christopher T Veldkamp, et al.
ACS Chemical Biology|May 26, 2016
Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoThomas B Sundberg, Yanke Liang, Huixian Wu, et al.
Scientific Reports|October 29, 2017
Behaviorally-determined sleep phenotypes are robustly associated with adaptive functioning in individuals with low functioning autismSimonne Cohen, Ben D Fulcher, Shantha M W Rajaratnam, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Nature Chemical Biology|August 15, 2017
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cellsLiv Johannessen, Thomas B Sundberg, Daniel J O'Connell, et al.
Molecular Cancer Therapeutics|December 30, 2021
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid TumorsJennifer R Diamond, Todd M Pitts, Dana Ungermannova, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Pageof 7